Skip to content

Body Water Content in Cyanotic Congenital Heart Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00000107
Enrollment
Unknown
Registered
2000-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Defects, Congenital

Keywords

Cyanotic Congenital Heart Disease

Brief summary

Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.

Interventions

None listed

Sponsors

National Center for Research Resources (NCRR)
Lead SponsorNIH

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Age
17 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Resting blood pressure below 140/90

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026